Technical Analysis for PSNL - Personalis, Inc.

Grade Last Price % Change Price Change
F 24.05 -5.94% -1.52
PSNL closed down 8.58 percent on Thursday, March 4, 2021, on 1.61 times normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical PSNL trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish -5.94%
New Downtrend Bearish -5.94%
Lower Bollinger Band Walk Weakness -5.94%
Wide Bands Range Expansion -5.94%
Below Lower BB Weakness -5.94%
Down 3 Days in a Row Weakness -5.94%
Lower Bollinger Band Touch Weakness -5.94%
Oversold Stochastic Weakness -5.94%
Multiple of Ten Bearish Other -14.02%
Wide Bands Range Expansion -14.02%
Older End-of-Day Signals for PSNL ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 1 ATR about 3 hours ago
60 Minute Opening Range Breakdown about 4 hours ago
2x Volume Pace about 4 hours ago
Down 10% about 4 hours ago
Fell Below Previous Day's Low about 4 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves approximately 45 biopharmaceutical customers, including a range of pharmaceutical companies. The company was founded in 2011 and is headquartered in Menlo Park, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Biology Pharmaceutical Telemedicine Telehealth Genomics Medical Genetics Molecular Diagnostics Cancer Therapies Applied Genetics Analysis Services Biopsy Treating Cancer Cancer Therapy Data Analysis Services

Is PSNL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 53.46
52 Week Low 4.27
Average Volume 1,096,323
200-Day Moving Average 26.05
50-Day Moving Average 38.95
20-Day Moving Average 36.01
10-Day Moving Average 32.16
Average True Range 3.76
ADX 25.48
+DI 13.74
-DI 40.14
Chandelier Exit (Long, 3 ATRs ) 32.70
Chandelier Exit (Short, 3 ATRs ) 34.93
Upper Bollinger Band 45.26
Lower Bollinger Band 26.75
Percent B (%b) -0.06
BandWidth 51.40
MACD Line -3.09
MACD Signal Line -1.91
MACD Histogram -1.1785
Fundamentals Value
Market Cap 995.51 Million
Num Shares 38.9 Million
EPS -4.74
Price-to-Earnings (P/E) Ratio -5.40
Price-to-Sales 11.76
Price-to-Book 5.31
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 32.59
Resistance 3 (R3) 32.73 30.54 31.42
Resistance 2 (R2) 30.54 28.75 30.47 31.03
Resistance 1 (R1) 28.05 27.64 26.96 27.91 30.64
Pivot Point 25.86 25.86 25.31 25.79 25.86
Support 1 (S1) 23.37 24.07 22.28 23.23 20.50
Support 2 (S2) 21.18 22.96 21.11 20.11
Support 3 (S3) 18.69 21.18 19.72
Support 4 (S4) 18.55